Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11.2 mg ZGN-440 for injectable suspension----[1] 193
21.8 mg ZGN-440 for injectable suspension----[1] 193
3Acetylcysteine[1] Acetylcysteine[1] D00221 --[21] 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
4Acomplia[1] Rimonabant[1] D05731 [1] CNR1 💬[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 193
5ACOMPLIA 20 mg film-coated tablets[1] Rimonabant[1] D05731 [1] CNR1 💬[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 193
6Acylated and unacylated ghrelin dosages[1] Lenomorelin---[3] 193, 201, 202
7Air----[3] 85, 97, 193
8ANASTROZOLE[1] Anastrozole[1] D00960 [1] CYP19A1 💬[3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬[3] 78, 86, 193
9AZP-531----[1] 193
10B. lactis B94----[1] 193
11Beloranib[1] Beloranib---[1] 193
12Byetta[1] Exenatide[1] D04121 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 6, 78, 193
13Cannabidiol[1] Cannabidiol[1] D10915 [2] CNR1,
CNR2 💬		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[18] 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271
14Cannabidiol Oral Solution[1] Cannabidiol[1] D10915 [2] CNR1,
CNR2 💬		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[4] 140, 144, 145, 193
15CBDV[1] Cannabidivarin---[1] 193
16CBDV Compound[1] Cannabidivarin---[1] 193
17Chloride[1] Chloride ion---[28] 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338
18Choline[1] Choline[1] D07690 --[4] 93, 171, 193, 299
19CSTI-500----[1] 193
20D.3.2 Product code where applicable13:----[1] 193
21DCCR----[1] 193
22Diazoxide[1] Diazoxide[1] D00294 [2] ABCC8,
KCNJ11 💬		[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬[2] 13, 193
23DIAZOXIDE CHOLINE[2] Choline,
Diazoxide		[2] D00294 ,
D07690 		[2] ABCC8,
KCNJ11 💬		[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬[1] 193
24Diazoxide choline controlled-release tablet[2] Choline,
Diazoxide		[2] D00294 ,
D07690 		[2] ABCC8,
KCNJ11 💬		[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬[1] 193
25EU/1/06/362/003: 5µg (1 pen)----[1] 193
26Eutropin----[2] 78, 193
27EXENATIDE[1] Exenatide[1] D04121 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[6] 6, 17, 72, 78, 193, 233
28FE 992097----[1] 193
29Fluimucil----[4] 85, 94, 193, 298
30Fluimucil (acetylcysteine)[1] Acetylcysteine[1] D00221 --[1] 193
31Follow-up study of the treated cohort----[1] 193
32GENOTONORM----[1] 193
33Genotonorm Miniquick 0,2 mg----[1] 193
34Genotropin----[5] 13, 78, 107, 187, 193
35GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made.[1] Somatotropin---[1] 193
36Ghrelin[1] Lenomorelin---[6] 6, 78, 193, 201, 202, 299
37GLWL-01----[1] 193
38Gold[1] Gold---[43] 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318
39Growth hormone[1] Somatotropin---[14] 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299
40Growth hormone (Genotonorm® or Omnitrope®)[1] Somatotropin---[2] 78, 193
41Guanfacine[1] Guanfacine[1] D08031 [1] ADRA2A 💬[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 193
42Guanfacine Extended Release[1] Guanfacine[1] D08031 [1] ADRA2A 💬[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 193
43Guanfacine extended release (GXR)[1] Guanfacine[1] D08031 [1] ADRA2A 💬[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 193
44H01BB02----[1] 193
45Human Growth Hormone[1] Somatotropin---[5] 78, 187, 193, 265, 276
46Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten[1] Somatotropin---[1] 193
47INN Not yet proposed----[1] 193
48Intranasal oxytocin[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[2] 127, 193
49Intranasal Oxytocin (IN-OXT)[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 193
50Liraglutide[1] Liraglutide[1] D06404 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 6, 75, 193
51Livoletide[1] Livoletide---[1] 193
52Medical air[2] Medical air,
Oxygen		[1] D00003 --[3] 85, 86, 193
53Medical Air vs Oxygen[2] Medical air,
Oxygen		[1] D00003 --[1] 193
54Metoprolol[1] Metoprolol[1] D02358 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[6] 17, 57, 58, 113, 193, 226
55Metoprolol succinate[1] Metoprolol[1] D02358 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 57, 58, 113, 193
56METOPROLOL SUCCINATE (PH. EUR.)[1] Metoprolol[1] D02358 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 193
57Metoprololsuccinat Orion 25mg----[1] 193
58Metoprololsuccinat ”Orion” 25mg----[1] 193
59NBT-NM108----[1] 193
60Norditropin SimpleXx----[5] 3, 78, 107, 193, 195
61Nutropin AQ----[4] 78, 134, 193, 299
62Octreotide[1] Octreotide[1] D00442 [1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[7] 67, 75, 84, 85, 89, 193, 227
63OMNITROPE[1] Somatotropin---[2] 78, 193
64OSSITOCINA----[1] 193
65OT----[1] 193
66Oxygen[1] Oxygen[1] D00003 --[13] 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330
67Oxytocin[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[7] 6, 72, 127, 168, 193, 206, 226
68Oxytocin (OXT) continuous[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 193
69Oxytocin nasal spray[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[2] 72, 193
70Physiological serum (Sodium chloride)[2] Chloride ion,
Sodium chloride		[1] D02056 --[1] 193
71Pitolisant[1] Pitolisant[1] D10749 [1] HRH3 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 113, 193
72Pitolisant oral tablets[1] Pitolisant[1] D10749 [1] HRH3 💬[1] Neuroactive ligand-receptor interaction 💬[1] 193
73Probiotic----[8] 2, 6, 93, 96, 97, 193, 266, 299
74R05CB01----[1] 193
75RAD011----[1] 193
76Rapamycin[1] Sirolimus[1] D00753 [1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[18] 15, 34, 35, 46, 49, 51, 53, 60, 61, 67, 86, 89, 96, 157, 158, 193, 256, 279
77RECOMBINANT HUMAN GROWTH HORMON----[1] 193
78RECOMBINANT HUMAN GROWTH HORMONE[1] Somatotropin---[4] 78, 193, 265, 276
79Recombinant Human Growth Hormone (rhGH) Injection[1] Somatotropin---[1] 193
80Recombinant Somatropin[1] Somatotropin---[1] 193
81RGH-706----[1] 193
82RhGH[1] Somatotropin---[6] 76, 78, 96, 193, 246, 337
83Rimonabant[1] Rimonabant[1] D05731 [1] CNR1 💬[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 193
84RM-493----[2] 193, 202
85Sandostatin LAR[1] Octreotide[1] D00442 [1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 67, 84, 193, 227
86Saxenda[1] Liraglutide[1] D06404 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 193
87Sodium chloride[2] Chloride ion,
Sodium chloride		[1] D02056 --[20] 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299
88Somatropin[1] Somatotropin---[19] 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
89Somatropin - adult cohort[1] Somatotropin---[1] 193
90Somatropin - GH naïve pediatric cohort[1] Somatotropin---[1] 193
91Somatropin - GH treated cohort[1] Somatotropin---[1] 193
92Subcutaneous Beloranib in Suspension[1] Beloranib---[1] 193
93Syntocinon[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[3] 6, 127, 193
94Syntocinon nasal spray[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 193
95Syntocinon®/- Spray[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 193
96Tesofensine[1] Tesofensine---[2] 6, 193
97TESOFENSINE CITRATE[1] Tesofensine---[1] 193
98Tesofensine/Metoprolol[2] Metoprolol,
Tesofensine		[1] D02358 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 193
99Tesomet----[1] 193
100TOPIRAMATE[1] Topiramate[1] D00537 [36] CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[53] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[6] 6, 97, 140, 144, 156, 193
101ZGN-440----[1] 193
102ZGN-440 for Injectable Suspension----[1] 193
103ZGN-440 sterile diluent----[1] 193